- $2.37bn
- $3.75bn
- $2.26bn
- 82
- 62
- 42
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,266 | 1,271 | 1,316 | 2,280 | 2,259 |
Cost of Revenue | |||||
Gross Profit | 472 | 461 | 491 | 698 | 740 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,159 | 1,173 | 1,193 | 2,323 | 2,236 |
Operating Profit | 107 | 98.2 | 123 | -42.9 | 22.8 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 115 | 97.5 | 123 | -114 | -78.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 101 | 86.9 | 103 | -74.3 | -29.7 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 101 | 86.9 | 103 | -74.3 | -29.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 101 | 86.9 | 103 | -74.3 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.22 | 5.08 | 5.5 | -1.1 | -0.114 |